
Overview
Lee Starker, MD, PhD, is a medical director of surgical oncology for the eastern region with a special interest in thyroid and parathyroid tumors and cancers, endocrine disorders, melanoma, hormones and metabolism, and cancer genetics. He is highly trained in pancreatic and complex hepatobiliary surgery. He also specializes in NanoKnife® to treat unresectable pancreatic and liver cancers as well as hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery for peritoneal malignancies.After completing his surgical residency at Yale New Haven Hospital in Connecticut and surgical oncology fellowship training at MD Anderson Cancer Center in Texas, Dr. Starker returned to his New Jersey roots. Prior to that, he earned a PhD in epigenetics and genetics of parathyroid tumors from Uppsala University in Sweden, where he was chief resident and fellow. While studying there, he received the Gold Humanism Award, which recognizes excellence in clinical care, leadership, compassion and dedication to service. He has also been named an NJ Top Doctor annually by NJ Monthly Magazine.Dr. Starker is widely published in various medical journals, including the World Journal of Oncology and International Journal of Endocrinology. He is a member of the Society of Surgical Oncology. Dr. Starker and his partners provide patients with the latest surgical innovations and clinical research options. He is a participating provider of the Atlantic Accountable Care Organization.
Dr. Starker is rated as an Advanced provider by MediFind in the treatment of Parathyroid Adenoma. His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.
His clinical research consists of co-authoring 18 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Parathyroid Adenoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Madison Ave,Carol G Simon Cancer Ctr, Morristown, NJ 07960
33 Upper Overlook Road, Suite L02, Summit, NJ 07901
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
New York University
Insoo Suh is a General Surgeon in New York, New York. Dr. Suh is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Adenoma. His top areas of expertise are Hyperparathyroidism, Parathyroid Adenoma, Parathyroid Cancer, Parathyroidectomy, and Thyroidectomy.
Endocrine Surgery At CentraState -Englishtown
Alexander Shifrin, MD, is an endocrine surgeon with Atlantic Medical Group Surgical Associates of CentraState and surgical director, CentraState Endocrine Program. He is board-certified in surgery by the American Board of Surgery, and in endocrine neck ultrasound and ultrasound-guided thyroid biopsy by the American College of Endocrinology. In addition, he is the first endocrine surgeon in the United States to have board certification in endocrine surgery (FEBS), a designation available only through the European Board of Surgery. He completed two fellowship training programs: one in trauma and surgical critical care, and a second in endocrine surgery.A national and international leader in the management of complex endocrine diseases, Dr. Shifrin has specific expertise in minimally invasive surgical procedures to treat endocrine cancers and diseases of the thyroid, parathyroid, and adrenal glands. These include thyroid gland diseases such as: thyroid cancer, multinodular goiter, Graves’ disease; parathyroid gland diseases such as: primary hyperparathyroidism, secondary and tertiary hyperparathyroidism; adrenal gland diseases such as: Cushing’s syndrome, primary hyperaldosteronism (Conn’s syndrome), pheochromocytoma, and adrenal incidentaloma; familial endocrine syndromes; and other hereditary endocrine syndromes. Utilizing an evidence-based approach, Dr. Shifrin employs state-of-the-art techniques to perform hundreds of surgeries each year with precision, accuracy, and extremely high success rates. He works in collaboration with other specialists to provide patients leading-edge cancer treatments in a safe environment. He is a Fellow of the American College of Surgeons (FACS), Fellow of the American College of Endocrinology (FACE), and Fellow of the International Society of Surgery (FISS).Dr. Shifrin has edited and authored several books and atlases, including the Atlas of Thyroid Surgery, Atlas of Parathyroid Surgery, Atlas of Adrenal Surgery, Atlas of Parathyroid Imaging and Pathology, Endocrine Emergencies, Advances in Treatment and Management in Surgical Endocrinology, and Endocrine Surgery Comprehensive Board Exam Guide, book chapters, and peer-reviewed papers. He is also a frequent speaker at national and international conferences.Dr. Shifrin pursued extensive surgery residency training at the Hospital of the University of Pennsylvania, followed by Penn State Milton S. Hershey Medical Center. Dr. Shifrin is a full Professor of Surgery at Hackensack Meridian School of Medicine and Clinical Associate Professor of Surgery at Rutgers Robert Wood Johnson Medical School. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shifrin is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Adenoma. His top areas of expertise are Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Hyperparathyroidism, and Osteitis Fibrosa.
Trustees Of Columbia University In The City Of New York
James Lee is a General Surgeon in New York, New York. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Adenoma. His top areas of expertise are Parathyroid Hyperplasia, Familial Isolated Hyperparathyroidism, Osteitis Fibrosa, Neonatal Severe Hyperparathyroidism, and Thymectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Starker isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Starker isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Starker isDistinguished. Learn about Familial Pancreatic Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Starker isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Follicular Thyroid CancerDr. Starker isAdvanced. Learn about Follicular Thyroid Cancer.
- Gallbladder DiseaseDr. Starker isAdvanced. Learn about Gallbladder Disease.
- Medullary Thyroid CarcinomaDr. Starker isAdvanced. Learn about Medullary Thyroid Carcinoma.
- Muscle Invasive Bladder CancerDr. Starker isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Starker isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- Adrenal CancerDr. Starker isExperienced. Learn about Adrenal Cancer.
- Ampullary CancerDr. Starker isExperienced. Learn about Ampullary Cancer.
- Bladder ReconstructionDr. Starker isExperienced. Learn about Bladder Reconstruction.
- Bone TumorDr. Starker isExperienced. Learn about Bone Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Starker isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Desmoplastic Small Round Cell TumorDr. Starker isExperienced. Learn about Desmoplastic Small Round Cell Tumor.

